Gain Therapeutics Inc
GANX
NASDAQ
Biotechnology
$2.12
USD
-0.05 (-2.08%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $94.49M
Volume 517.4K
Price Target
$5.00 – $8.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $8.00 and a min estimate of $5.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$6.50
Implied Upside
+206.6%
Analyst Covering
2
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Raghuram Selvaraju | HC Wainwright & Co. | Buy | Reiterated | 1 month ago | Plus | Plus | Plus |
Thomas Shrader | BTIG | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
